Immucor Resumes Stock Repurchase Program
November 11 2005 - 8:15AM
PR Newswire (US)
NORCROSS, Ga., Nov. 11 /PRNewswire-FirstCall/ -- Immucor, Inc.
(NASDAQ:BLUDE), the global leader in providing automated
instrument-reagent systems to the blood transfusion industry, today
announced that it intends to resume repurchases from time to time
under its existing stock repurchase program, at times and in
amounts to be determined by the Company's management and as market
conditions allow. The Company has not made any repurchases under
this program since the commencement of its previously reported
internal investigation. With the completion of the internal
investigation and the Company's filing of its Quarterly Report on
Form 10-Q for the period ended August 31, 2005, the Company's Board
of Directors has authorized the Company to resume repurchases under
the program. As of November 11, 2005, 1,002,750 shares remain
authorized for repurchase under the program. Founded in 1982,
Immucor manufactures and sells a complete line of reagents and
systems used by hospitals, reference laboratories and donor centers
to detect and identify certain properties of the cell and serum
components of blood prior to transfusion. Immucor markets a
complete family of automated instrumentation for all of our market
segments. For more information on Immucor, please visit our website
at http://www.immucor.com/. This press release contains
forward-looking statements as that term is defined in the Private
Securities Reform Act of 1995, including, without limitation,
statements concerning the Company's expectations, beliefs,
intentions or strategies regarding the future. All forward-looking
statements included in this document are based on information
available to the Company on the date hereof, and the Company
assumes no obligation to update any such forward-looking
statements. Further risks are detailed in the Company's filings
with the Securities and Exchange Commission, including those set
forth in the Company's most recent Form 10-K and Quarterly Reports
on Form 10-Q. DATASOURCE: Immucor, Inc. CONTACT: Edward Gallup of
Immucor, Inc., +1-770-441-2051 Web site: http://www.immucor.com/
Copyright
Immucor (NASDAQ:BLUDE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Immucor (NASDAQ:BLUDE)
Historical Stock Chart
From Oct 2023 to Oct 2024